Mackenzie Tatananni, Barron's Journalist Profile

Articles

A Perplexity AI Deal Could Be Just What Apple Stock Needs, Analysts Say. Others Aren’t So Sure.

3 days ago | barrons.com | Mackenzie Tatananni

Many on Wall Street think Apple has been too slow in developing artificial-intelligence features for its numerous tech products. But that view could change if a Bloomberg report is true the tech giant is looking to partner with an AI-powered search engine.
Lyft Stock Gets an Upgrade. Why Competition in the AV Market Is No Problem.

3 days ago | barrons.com | Mackenzie Tatananni

Lyft Stock Gets an Upgrade. Why Competition in the AV Market Is No Problem.
Oklo Stock Gets a Downgrade as Nuclear Startup Takes Uncharted Path

4 days ago | barrons.com | Mackenzie Tatananni

Oklo stock has taken off as the artificial-intelligence boom creates new interest in nuclear power. But skepticism remains about when its reactors will come on line, leaving some on Wall Street unsure of where to stand.
Super Micro Computer Is the Worst-Performing Stock in the S&P 500 Today

4 days ago | barrons.com | Mackenzie Tatananni

Super Micro Computer Is the Worst-Performing Stock in the S&P 500 Today. Here’s Why.
Trump Media Plans Stock Buyback. It’s Still Going to Buy Bitcoin.

4 days ago | barrons.com | Mackenzie Tatananni

Trump Media and Technology Group said its board had approved a buyback of up to $400 million of the company’s common stock, weeks after vowing to sell millions of dollars worth of shares in pursuit of its Bitcoin treasury aspirations.
Novo Nordisk Stock Tumbles on CagriSema Trial Data. Why Investors Have Doubts.

5 days ago | barrons.com | Mackenzie Tatananni

Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled as the results missed investors’ expectations and reignited concerns about Novo’s rivalry with Eli Lilly .
Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership

5 days ago | barrons.com | Mackenzie Tatananni

Shares of Hims & Hers Health plummeted in premarket trading Monday after Novo Nordisk terminated its partnership with the telehealth company, citing concerns about “illegal mass compounding and deceptive marketing.”
Couchbase Stock Soars 30% as AI Database Platform Gets $1.5 Billion Buyout Offer

1 week ago | barrons.com | Mackenzie Tatananni

Couchbase stock headed for record gains Friday after the platform for artificial-intelligence developers said it had entered into a definitive agreement with Haveli Investments to be taken private in a $1.5 billion buyout.
Kroger Stock Jumps After Earnings Beat Expectations

1 week ago | barrons.com | Mackenzie Tatananni

Kroger reported fiscal first-quarter revenue that narrowly missed Wall Street expectations and the grocer maintained its overall fiscal-year guidance against an “uncertain” macro backdrop.
Accenture Earnings Beat Expectations. Why the Stock Is Falling Anyway.

1 week ago | barrons.com | Mackenzie Tatananni

Accenture reported better-than-expected earnings for the fiscal third quarter but shares fell in premarket trading Friday as the global consulting company announced a handful of leadership changes and said bookings had declined yet again.